Articles
| Open Access | HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF): CLINICAL CHALLENGES AND FUTURE THERAPIES
Situ Jingcheng , x
Published Date
2025-10-07
Pages
88
2
2
Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly 50% of heart failure cases. This study reviews pathophysiology, diagnostic difficulties, and treatment prospects.
Keywords
HFpEF, diastolic dysfunction, biomarkers, clinical management
References
Borlaug BA. HFpEF: Pathophysiology and therapy. Circulation. 2021.
Solomon SD, et al. DAPA-HF trial. NEJM, 2020.
Article Statistics
Downloads
Download data is not yet available.
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Download Citations
How to Cite
HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF): CLINICAL CHALLENGES AND FUTURE THERAPIES. (2025). International Journal of Artificial Intelligence, 5(10), 88. https://www.academicpublishers.org/journals/index.php/ijai/article/view/6709